James F Sumowski, PhD
img_James F Sumowski
Are you a patient?
Research Topics
Cognitive Neuroscience, Depression, Memory, Multiple Sclerosis
Reserve against Cognitive Decline Due to Multiple Sclerosis
Cognitive decline is common among persons with neurologic diseases, including multiple sclerosis (MS); however, some persons are better able to withstand neurologic disease without difficulties in thinking or memory. Dr. Sumowski's research seeks to identify sources of "reserve" against cognitive decline in persons with MS. He has shown that persons with MS who lead more mentally-active lifestyles (e.g., reading, hobbies) are at lower risk for disease-related cognitive decline. Dr. Sumowski's current work seeks to identify a range of modifiable lifestyle factors contributing to reserve, with the goal of advancing primary prevention of cognitive difficulties due to MS.
Memory Treatments for Persons with Multiple Sclerosis
Memory deficits are among the most common cognitive difficulties experienced by persons with multiple sclerosis (MS), with negative consequences for employment and overall quality of life. There are currently no validated treatments for MS memory impairment. Dr. Sumowski has published early stage research investigating memory interventions through the use of cognitive strategies, lifestyle modifications, and pharmaceutical interventions. Dr. Sumowski is engaging in research to better understand the neural basis of memory deficits due to MS, which will inform the development of novel treatments with greater promise for success. 

BA, Seton Hall University

PhD, Columbia University

Internship, Clinical Neuropsychology, Long Island Jewish Medical Center

Fellowship, Clinical Neuropsychology, Rutgers New Jersey Medical School-Pathology

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Sumowski did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.